Cleared Traditional

K260906 - a2z-Abdo-Triage

K260906 is an FDA 510(k) clearance for a2z-Abdo-Triage, manufactured by A2z Radiology Ai, Inc.. The device is a Class 2 Radiology device with product code QAS cleared through the Traditional 510(k) pathway after a 181-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2026
Decision
181d
Days
Class 2
Risk

K260906 is an FDA 510(k) clearance for the a2z-Abdo-Triage. Classified as Radiological Computer-assisted Triage And Notification Software (product code QAS), Class II - Special Controls.

Submitted by A2z Radiology Ai, Inc. (Boston, US). The FDA issued a Cleared decision on September 16, 2026 after a review of 181 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2080 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all A2z Radiology Ai, Inc. devices

FDA 510(k) Submission Details - K260906

510(k) Number K260906 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 19, 2026
Decision Date September 16, 2026
Days to Decision 181 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized Yes - Predetermined Change Control Plan authorized FDA has pre-authorized specific future modifications to this device, a pathway common in AI/SaMD devices.
Regulatory Context
Review time vs. panel average
74d slower than avg
Panel avg: 107d · This submission: 181d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. PCCP authorized - AI/SaMD pathway.

QAS Device Classification - Class 2, Special Controls

Product Code QAS Radiological Computer-assisted Triage And Notification Software
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2080
Definition Radiological Computer-assisted Triage And Notification Software Is An Image Processing Device Intended To Aid In Prioritization And Triage Of Time Sensitive Patient Detection And Diagnosis Based On The Analysis Of Medical Images Acquired From Radiological Signal Acquisition Systems. The Device Identifies Or Prioritizes Time Sensitive Imaging For Review By Prespecified Clinical Users Based On Software-based Image Analysis But Does Not Provide Information From The Image Analysis Other Than Triage And Notification .
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - QAS Radiological Computer-assisted Triage And Notification Software

All 87
Devices cleared under the same product code (QAS) and FDA review panel - the closest regulatory comparables to K260906.
Rapid Vessel Occlusion (Rapid VO)
K261085 · Ischemaview · Jul 2026
Vascular Assist Occlusion Triage (VAOT) (v1.0)
K260729 · GuideAI Health · Jun 2026
BriefCase-Triage
K261317 · Aidoc Medical , Ltd. · May 2026
EFAI ERSUITE CT APPENDICITIS ASSESSMENT SYSTEM (APPEN-CT-100)
K253163 · Ever Fortune.Ai, Co., Ltd. · Apr 2026
JLK-NCCT
K252421 · JLK, Inc. · Mar 2026
Annalise Enterprise
K253818 · Harrison-AI Medical Pty, Ltd. · Mar 2026